{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:59:27Z","timestamp":1761469167365,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.transci.2022.103593","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T12:57:48Z","timestamp":1667307468000},"page":"103593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Apheresis and COVID-19 in intensive care unit (ICU)"],"prefix":"10.1016","volume":"61","author":[{"given":"Zikou","family":"Xanthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polychronidou","family":"Vasiliki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloizos","family":"Stavros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.transci.2022.103593_bib1","doi-asserted-by":"crossref","first-page":"ofaa105","DOI":"10.1093\/ofid\/ofaa105","article-title":"Coronavirus disease 2019 treatment: a review of early and emerging options","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.transci.2022.103593_bib2","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1056\/NEJMp2003762","article-title":"Responding to Covid\u201019\u2013A once\u2010in\u2010a\u2010century pandemic?","volume":"382","author":"Gates","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.transci.2022.103593_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/M20-6976","article-title":"The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review","volume":"174","author":"Oran","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transci.2022.103593_bib4","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID\u201019) in China","volume":"41","author":"Novel CPERE","year":"2020","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/j.transci.2022.103593_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID\u201019 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2022.103593_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.transci.2022.103593_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000507039","article-title":"Coronavirus epidemic and extracorporeal therapies in intensive care: Si vis pacem para bellum","volume":"49","author":"Ronco","year":"2020","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2022.103593_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2022.103593_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000508125","article-title":"Extracorporeal blood purification and organ support in the critically Ill patient during COVID-19 pandemic: expert review and recommendation","volume":"50","author":"Ronco","year":"2021","journal-title":"Blood Purif"},{"issue":"1","key":"10.1016\/j.transci.2022.103593_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.transci.2022.103593_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/medicina58020144","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina"},{"issue":"1","key":"10.1016\/j.transci.2022.103593_bib12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.transci.2022.103593_bib13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.transci.2022.103593_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.transci.2022.103593_bib15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/j.ajkd.2016.02.049","article-title":"High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial","volume":"68","author":"Park","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transci.2022.103593_bib16","first-page":"582","article-title":"Blood purification in sepsis and systemic inflammation","volume":"27","author":"Feng","year":"2021","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.transci.2022.103593_bib17","article-title":"Extracorporeal hemoperfusion as a potential therapeutic option for severe COVID-19 patients; a narrative review","volume":"8","author":"Safari","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"10.1016\/j.transci.2022.103593_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40560-021-00586-0","article-title":"Blood purification could tackle COVID-19?","volume":"9","author":"Yamada","year":"2021","journal-title":"J Intensive Care"},{"key":"10.1016\/j.transci.2022.103593_bib19","unstructured":"Nadim M.K., Forni L.G., Mehta R.L. COVID-19- associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup."},{"key":"10.1016\/j.transci.2022.103593_bib20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ccc.2012.04.009","article-title":"The role of plasmapheresis in critical illness","volume":"28","author":"Nguyen","year":"2012","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.transci.2022.103593_bib21","unstructured":"Sarfraz A., Makkar S.S., Sarfraz Z. Therapeutic Plasma Exchange and COVID-19: A Rapid Review. Journal of Clinical Immunology & Immunotherapy."},{"key":"10.1016\/j.transci.2022.103593_bib22","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","article-title":"Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial","volume":"28","author":"Busund","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2022.103593_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-014-0699-2","article-title":"The ef\ufb01cacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis","volume":"18","author":"Rimmer","year":"2014","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.transci.2022.103593_bib24","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PCC.0b013e3181e2a569","article-title":"Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A \u2013 an associated respiratory failure and hemodynamic shock","volume":"12","author":"Patel","year":"2011","journal-title":"Pedia Crit Care Med"},{"issue":"4","key":"10.1016\/j.transci.2022.103593_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bjh.16890","article-title":"Efficacy of therapeutic plasma exchange in severe COVID-19 patients","volume":"190","author":"Zhang","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.transci.2022.103593_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s13054-020-03171-3","article-title":"Plasma exchange in critically ill COVID-19 patients","volume":"24","author":"Morath","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2022.103593_bib27","first-page":"8","article-title":"The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure","author":"Keith","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.transci.2022.103593_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-020-2836-4","article-title":"A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19","volume":"24","author":"Keith","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2022.103593_bib29","doi-asserted-by":"crossref","unstructured":"Kamran S.M., Mirza Z.H., Naseem A. et al., Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study. PLoS ONE 16(1): e0244853.","DOI":"10.1371\/journal.pone.0244853"},{"key":"10.1016\/j.transci.2022.103593_bib30","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13054-020-03215-8","article-title":"Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study","volume":"24","author":"Gucyetmez","year":"2020","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.transci.2022.103593_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106334","article-title":"Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial","volume":"57","author":"Faqihi","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.transci.2022.103593_bib32","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.3390\/ijms221910238","article-title":"Renal replacement techniques in septic shock.","volume":"22","author":"Hellman","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.transci.2022.103593_bib33","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5152\/eurasianjmed.2021.20151","article-title":"Alternative treatment method for novel coronavirus disease 2019: coupled plasma filtration adsorption","volume":"53","author":"Ciftci","year":"2021","journal-title":"Eurasia J Med"},{"issue":"1","key":"10.1016\/j.transci.2022.103593_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5798\/dicletip.1086205","article-title":"Results of coupled plasma filtration adsorption (CPFA) treatment applied to critical COVID-19 Patients in Intensive Care Unit","volume":"49","author":"Ert\u00fcrk","year":"2022","journal-title":"Dicle T\u0131p Derg \/ Dicle Med J"},{"issue":"1","key":"10.1016\/j.transci.2022.103593_bib35","article-title":"Extracorporeal hemoperfusion as a potential therapeutic option for severe COVID-19 patients; a narrative review","volume":"8","author":"Safari","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"10.1016\/j.transci.2022.103593_bib36","article-title":"The use of cytosorb therapy in critically Ill COVID-19 patients: review of the rationale and current clinical experiences","volume":"Volume","author":"Ruiz-Rodr\u0131guez","year":"2021","journal-title":"Crit Care Res Pract"},{"issue":"23","key":"10.1016\/j.transci.2022.103593_bib37","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Rosee","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.transci.2022.103593_bib38","article-title":"Management of patients on dialysis and with kidney transplant during COVID-19 coronavirus infection","volume":"5","author":"Alberici","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.transci.2022.103593_bib39","unstructured":"F.D.A., CytoSorb 300 mL Device Approved by FDA for Emergency Treatment of COVID-19, FDA, Silver Spring, MD, USA, 2020."},{"issue":"5","key":"10.1016\/j.transci.2022.103593_bib40","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1111\/aor.13864","article-title":"Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: a case-series","volume":"vol. 45","author":"Alharthy","year":"2021","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2022.103593_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13054-020-03130-y","article-title":"Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation","volume":"24","author":"Rieder","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.transci.2022.103593_bib42","article-title":"Effects of tocilizumab versus hemoadsorption combined with tocilizumab in patients with SARS-CoV-2 pneumonia: Preliminary results","author":"Berlot","year":"2021","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.transci.2022.103593_bib43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1159\/000511725","article-title":"Hemoperfusion with CytoSorb as adjuvant therapy in critically Ill patients with SARS-CoV2 pneumonia","volume":"50","author":"Rampino","year":"2021","journal-title":"Blood Purif"},{"issue":"Number 11","key":"10.1016\/j.transci.2022.103593_bib44","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202011-4140LE","article-title":"Longitudinal cytokine profiling in patients with severe COVID-19 on extracorporeal membrane oxygenation and hemoadsorption","volume":"Volume 203","author":"Lebreton","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.transci.2022.103593_bib45","doi-asserted-by":"crossref","unstructured":"Stockmann H., Thelen P., Stroben F., et al., CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study. Critical Care Medicine, DOI: 10.1097\/CCM.0000000000005493.","DOI":"10.1097\/CCM.0000000000005493"},{"issue":"7","key":"10.1016\/j.transci.2022.103593_bib46","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-2600(21)00177-6","article-title":"Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial","volume":"9","author":"Supady","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.transci.2022.103593_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13613-019-0491-1","article-title":"Hemoadsorption therapy in the critically ill: solid base but clinical haze","volume":"9","author":"Honor\u00e9","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"23","key":"10.1016\/j.transci.2022.103593_bib48","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock the EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.transci.2022.103593_bib49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","article-title":"Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial","volume":"41","author":"Payen","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.transci.2022.103593_bib50","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","article-title":"Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level. The EUPHRATES Randomized Clinical Trial","volume":"320","author":"Dellinger","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2022.103593_bib51","doi-asserted-by":"crossref","unstructured":"Klein D.J., Foster D., Schorr C.A., et al., The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. doi: 10.1186\/1745\u20136215-15\u2013218.","DOI":"10.1186\/1745-6215-15-218"},{"key":"10.1016\/j.transci.2022.103593_bib52","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1744-9987.2010.00872.x","article-title":"Endotoxin adsorption therapy for a patient with severe pneumonia resulting from novel influenza A (H1N1) virus infection","volume":"15","author":"Araki","year":"2011","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2022.103593_bib53","first-page":"1","article-title":"Polymyxin B hemoperfusion in coronavirus disease 2019 patient with endotoxic shock: Case series from EUPHAS2 registry","volume":"00","author":"De Rosa","year":"2021","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2022.103593_bib54","unstructured":"Kuwana T., Kinoshita K., Hirabayashi M. et al., PMX-DHP Therapy for Dyspnea and Deoxygenation in Severe COVID-19 Pneumonia: A Case Series. doi.org\/10.2147\/IDR.S299023."},{"key":"10.1016\/j.transci.2022.103593_bib55","unstructured":"Monastra L., Perrella A., Garzia R. et al., Polymyxin B hemoperfusion therapy and extracorporeal CO2 removal in a patient with COVID-19: A case report."},{"issue":"3","key":"10.1016\/j.transci.2022.103593_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jca.21861","article-title":"Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19","volume":"36","author":"Katagiri","year":"2021","journal-title":"J Clin Apher"},{"key":"10.1016\/j.transci.2022.103593_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2021.100937","article-title":"Hemoperfusion as a therapeutic method for patients with severe COVID-19: a retrospective study","author":"Soleimani","year":"2021","journal-title":"N Microbes N Infect"},{"key":"10.1016\/j.transci.2022.103593_bib58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jgar.2020.04.024","article-title":"Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19","author":"Dastan","year":"2020","journal-title":"J ofGlobal Antimicrob Resistance21"},{"key":"10.1016\/j.transci.2022.103593_bib59","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12882-020-02020-3","article-title":"Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19)","volume":"21","author":"Asgharpour","year":"2020","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1016\/j.transci.2022.103593_bib60","first-page":"189","article-title":"The role of hemoperfusion in COVID-19 infection: a case series","volume":"7","author":"Amirsavadkouhi","year":"2021","journal-title":"Arch Anesthesiol Crit Care"},{"key":"10.1016\/j.transci.2022.103593_bib61","doi-asserted-by":"crossref","unstructured":"Surasit K. and Srisawat N. The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study. Blood Purif DOI: 10.1159\/000521713.","DOI":"10.1159\/000521713"},{"key":"10.1016\/j.transci.2022.103593_bib62","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000511391","article-title":"Hemoperfusion as a potential treatment for critically Ill COVID-19 patients with cytokine storm","volume":"50","author":"Shadvar","year":"2021","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2022.103593_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/jrms.JRMS_1122_20","article-title":"Hemoperfusion in patients with severe COVID\u201119 respiratory failure, lifesaving or not?","volume":"26","author":"Abbasi","year":"2021","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.transci.2022.103593_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","article-title":"In vitro comparison of the adsorption of inflammatory mediators by blood purification devices","volume":"6","author":"Malard","year":"2018","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.transci.2022.103593_bib65","first-page":"491","article-title":"Application of endotoxin and cytokine adsorption haemo\ufb01lter in septic acute kidney injury due to gram-negative bacterial infection","volume":"19","author":"Shum","year":"2013","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.transci.2022.103593_bib66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000499589","article-title":"Continuous renal replacement therapy with the adsorbing \ufb01lter oXiris in septic patients: a case series","volume":"47","author":"Turani","year":"2019","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2022.103593_bib67","first-page":"1","article-title":"Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients","author":"Premu\u017ei","year":"2021","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2022.103593_bib68","first-page":"1","article-title":"The absorbing filter Oxiris in severe coronavirus disease 2019 patients: a case series","volume":"00","author":"Zhang","year":"2020","journal-title":"Artif Organs"},{"key":"10.1016\/j.transci.2022.103593_bib69","article-title":"Extracorporeal blood purification in moderate and severe COVID-19 patients: a prospective cohort study","author":"Rosalia","year":"2021","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2022.103593_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.817793","article-title":"Continuous renal replacement therapy with oXiris filter may not be an effective resolution to alleviate cytokine release syndrome in non-AKI patients with severe and critical COVID-19","volume":"13","author":"Kang","year":"2022","journal-title":"Front Pharm"},{"key":"10.1016\/j.transci.2022.103593_bib71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s41100-018-0170-y","article-title":"The clinical evaluation of novel polymethyl methacrylate membrane with a modified membrane surface: a multicenter pilot study","volume":"4","author":"Uchiumi","year":"2018","journal-title":"Ren Replace Ther"},{"key":"10.1016\/j.transci.2022.103593_bib72","first-page":"1","article-title":"Continuous renal replacement therapy for a patient with severe COVID-19","author":"Katagiri","year":"2020","journal-title":"Blood Purif"},{"issue":"591714","key":"10.1016\/j.transci.2022.103593_bib73","first-page":"155","article-title":"C-Reactive mProtein Apheresis as anti-inflammatory therapy in acute myocardial infarction: results of the CAMI-1 study","volume":"8","author":"Ries","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.transci.2022.103593_bib74","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/1744-9987.12796","article-title":"PentraSorb C-reactive protein: characterization of the selective C-reactive protein adsorber resin","volume":"23","author":"Mattecka","year":"2019","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2022.103593_bib75","unstructured":"Ringel J., Ramlow A., Bock C. and Sheriff A. Case report: C-Reactive Protein Apheresis in a Patient with Covid-19 and Fulminant CRP Increase. Frontiers in Immunology, doi: 10.3389\/timmu.2021.708101."},{"key":"10.1016\/j.transci.2022.103593_bib76","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.925020","article-title":"First-in-Man: case report of selective C-reactive protein apheresis in a patient with SARS-CoV-2 infection","volume":"21","author":"Torzewski","year":"2020","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.transci.2022.103593_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2020.07.025","article-title":"Adsorptive granulocyte and monocyte apheresis: a potentially relevant therapeutic option for COVID-19","volume":"99","author":"Kanekura","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"6","key":"10.1016\/j.transci.2022.103593_bib78","doi-asserted-by":"crossref","first-page":"511","DOI":"10.17235\/reed.2020.7156\/2020","article-title":"The effect of Adacolumn on ulcerative colitis with COVID-19","volume":"112","author":"Rold\u00e1n","year":"2020","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.transci.2022.103593_bib79","first-page":"12","article-title":"The role of continuous renal replacement therapy (Crrt) in Coronavirus disease 2019 (Covid-19) patients","author":"Paramitha","year":"2021","journal-title":"Trends Anaesth Crit Care 39"},{"key":"10.1016\/j.transci.2022.103593_bib80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12882-021-02296-z","article-title":"Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study","volume":"22","author":"Lowe","year":"2021","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transci.2022.103593_bib81","unstructured":"Ottolina D., Zazzeron L., Trevisi L. Acute kidney injury (AKI) in patients with Covid\u201119 infection is associated with ventilatory management with elevated positive end\u2011expiratory pressure (PEEP). Journal of Nephrology doi.org\/10.1007\/s40620\u2013021-01100\u20133."},{"key":"10.1016\/j.transci.2022.103593_bib82","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(20)30229-0","article-title":"Management of acute kidney injury in patients with COVID-19","volume":"8","author":"Ronco","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.transci.2022.103593_bib83","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3390\/jcm9051529","article-title":"A continuous renal replacement therapy protocol for patients with acute kidney injury in intensive care unit with COVID-19","volume":"9","author":"Nalesso","year":"2020","journal-title":"J Clin Med"},{"issue":"10257","key":"10.1016\/j.transci.2022.103593_bib84","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(20)32008-0","article-title":"Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry","volume":"396","author":"Barbaro","year":"2020","journal-title":"Lancet"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222002932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050222002932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:55:55Z","timestamp":1761468955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050222002932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1473050222002932"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2022.103593","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apheresis and COVID-19 in intensive care unit (ICU)","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2022.103593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103593"}}